D. E. Shaw & Co., Inc. Tandem Diabetes Care Inc Transaction History

D. E. Shaw & Co., Inc.

$122 Billion
Q4 2024

A detailed history of D. E. Shaw & Co., Inc. transactions in Tandem Diabetes Care Inc stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 20,300 shares of TNDM stock, worth $345,709. This represents 0.0% of its overall portfolio holdings.

Number of Shares

20,300

Holding current value

$345,709

% of portfolio

0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$22.09 - $35.41 $479,529 - $768,680	-21,708 Reduced 23.31%	71,432 $2.53 Million
Q4 2023 Feb 14, 2024	SELL	$14.28 - $31.03 $2.25 Million - $4.9 Million	-157,804 Reduced 62.88%	93,140 $2.76 Million
Q3 2023 Nov 14, 2023	SELL	$19.33 - $36.22 $6.79 Million - $12.7 Million	-351,116 Reduced 58.32%	250,944 $5.21 Million
Q2 2023 Aug 14, 2023	BUY	$24.18 - $42.46 $8.62 Million - $15.1 Million	356,493 Added 145.17%	602,060 $14.8 Million
Q1 2023 May 15, 2023	BUY	$35.86 - $46.5 $3.36 Million - $4.35 Million	93,572 Added 61.56%	245,567 $9.97 Million
Q4 2022 Feb 14, 2023	BUY	$35.49 - $56.15 $4.6 Million - $7.28 Million	129,592 Added 578.46%	151,995 $6.83 Million
Q3 2022 Nov 14, 2022	SELL	$43.76 - $68.97 $213,811 - $336,987	-4,886 Reduced 17.9%	22,403 $1.07 Million
Q2 2022 Aug 15, 2022	BUY	$53.22 - $123.09 $1.06 Million - $2.44 Million	19,845 Added 266.59%	27,289 $1.62 Million
Q1 2022 May 16, 2022	SELL	$101.89 - $150.09 $1.17 Million - $1.72 Million	-11,478 Reduced 60.66%	7,444 $866,000
Q4 2021 Feb 14, 2022	BUY	$118.18 - $153.21 $550,364 - $713,498	4,657 Added 32.65%	18,922 $2.85 Million
Q3 2021 Nov 15, 2021	SELL	$93.51 - $129.4 $86,870 - $120,212	-929 Reduced 6.11%	14,265 $1.7 Million
Q2 2021 Aug 16, 2021	SELL	$77.0 - $100.19 $245,399 - $319,305	-3,187 Reduced 17.34%	15,194 $1.48 Million
Q1 2021 May 17, 2021	SELL	$81.28 - $104.34 $1.03 Million - $1.32 Million	-12,697 Reduced 40.86%	18,381 $1.62 Million
Q4 2020 Feb 16, 2021	SELL	$86.4 - $121.75 $869,011 - $1.22 Million	-10,058 Reduced 24.45%	31,078 $2.97 Million
Q3 2020 Nov 16, 2020	BUY	$95.43 - $116.09 $2.18 Million - $2.65 Million	22,844 Added 124.89%	41,136 $4.67 Million
Q2 2020 Aug 14, 2020	BUY	$60.05 - $98.92 $770,081 - $1.27 Million	12,824 Added 234.53%	18,292 $1.81 Million
Q1 2020 May 15, 2020	SELL	$47.37 - $90.04 $24,395 - $46,370	-515 Reduced 8.61%	5,468 $352,000
Q3 2019 Nov 14, 2019	SELL	$57.11 - $73.3 $29.3 Million - $37.6 Million	-513,541 Reduced 98.85%	5,983 $353,000
Q1 2019 May 15, 2019	BUY	$32.25 - $73.56 $15.6 Million - $35.6 Million	483,553 Added 1344.29%	519,524 $33 Million
Q4 2018 Feb 14, 2019	SELL	$28.45 - $40.65 $912,448 - $1.3 Million	-32,072 Reduced 47.13%	35,971 $1.37 Million
Q3 2018 Nov 14, 2018	BUY	$21.39 - $51.17 $1.46 Million - $3.48 Million	68,043 New	68,043 $2.92 Million

Others Institutions Holding TNDM

# of Institutions

339

Shares Held

70.8M

Call Options Held

3.11M

Put Options Held

181K

View Full List

About TANDEM DIABETES CARE INC

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $1.09B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

More about TNDM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account